+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-07-27Number of Pages: 139

Albumin Market (Type - Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin; Application - Blood Volumizer, Drug Formulation and Vaccines, and Life Sciences) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin Market

4. Market Overview
     4.1. Introduction
          4.1.1. Product Definition
          4.1.2. Industry Evolution / Developments
     4.2. Market Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
          4.4.1. Drivers
          4.4.2. Restraints
          4.4.3. Opportunities
          4.4.4. Trends
     4.5. Albumin Market Analysis and Forecast, 2016 – 2024
          4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Albumin Market  - Global Supply Demand Scenario
     4.7. Market Outlook
     4.8. Porter’s five forces analysis

5. Global Albumin Market Analysis and Forecasts, By Product Type
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value (US$ Mn) Forecast By Product Type
          5.4.1. Human Serum Albumin
          5.4.2. Bovine Serum Albumin
          5.4.3. Recombinant Albumin
     5.5. Comparison Matrix
     5.6. Market Attractiveness By Product Type

6. Global Albumin Market Analysis and Forecasts, By Application
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value (US$ Mn) Forecast By Application
          6.4.1. Blood Volumizer
          6.4.2. Drug Formulation and Vaccines
          6.4.3. Life Sciences
          6.4.4. Others
     6.5. Comparison Matrix
     6.6. Market Attractiveness By Application

7. Global Albumin Market Analysis and Forecasts, By Region
     7.1. Key Findings
     7.2. Policies and Regulations
     7.3. Market Value (US$ Mn) Forecast By Region
          7.3.1. North America
          7.3.2. Europe
          7.3.3. Asia Pacific
          7.3.4. Rest of the World
     7.4. Market Attractiveness By Region

8. North America Albumin Market Analysis and Forecast
     8.1. Introduction
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value (US$ Mn) Forecast By Product Type
          8.4.1. Human Serum Albumin
          8.4.2. Bovine Serum Albumin
          8.4.3. Recombinant Albumin
     8.5. Market Value (US$ Mn) Forecast By Application
          8.5.1. Blood Volumizer
          8.5.2. Drug Formulation and Vaccines
          8.5.3. Life Sciences
          8.5.4. Others
     8.6. Market Size (US$ Mn) Forecast, By Country
          8.6.1. U.S.
          8.6.2. Canada
     8.7. Market Attractiveness Analysis
          8.7.1. By Product Type
          8.7.2. By Application
          8.7.3. By Country

9. Europe Albumin Market Analysis and Forecast
     9.1. Introduction
     9.2. Key Findings / Developments
     9.3. Key Trends
     9.4. Market Value (US$ Mn) Forecast By Product Type
          9.4.1. Human Serum Albumin
          9.4.2. Bovine Serum Albumin
          9.4.3. Recombinant Albumin
     9.5. Market Value (US$ Mn) Forecast By Application
          9.5.1. Blood Volumizer
          9.5.2. Drug Formulation and Vaccines
          9.5.3. Life Sciences
          9.5.4. Others
     9.6. Market Size (US$ Mn) Forecast, By Country
          9.6.1. Germany
          9.6.2. U.K.
          9.6.3. France
          9.6.4. Spain
          9.6.5. Italy
          9.6.6. Rest of Europe
     9.7. Market Attractiveness Analysis
          9.7.1. By Product Type
          9.7.2. By Application
          9.7.3. By Country

10. Asia Pacific Albumin Market Analysis and Forecast
     10.1. Introduction
     10.2. Key Findings / Developments
     10.3. Key Trends
     10.4. Market Value (US$ Mn) Forecast By Product Type
          10.4.1. Human Serum Albumin
          10.4.2. Bovine Serum Albumin
          10.4.3. Recombinant Albumin
     10.5. Market Value (US$ Mn) Forecast By Application
          10.5.1. Blood Volumizer
          10.5.2. Drug Formulation and Vaccines
          10.5.3. Life Sciences
          10.5.4. Others
     10.6. Market Size (US$ Mn) Forecast, By Country
          10.6.1. Japan
          10.6.2. China
          10.6.3. India
          10.6.4. Australia & New Zealand
          10.6.5. Rest of Asia Pacific
     10.7. Market Attractiveness Analysis
          10.7.1. By Product Type
          10.7.2. By Application
          10.7.3. By Country

11. Rest of the World Albumin Market  Analysis and Forecast
     11.1. Introduction
     11.2. Key Findings / Developments
     11.3. Key Trends
     11.4. Market Value (US$ Mn) Forecast By Product Type
          11.4.1. Human Serum Albumin
          11.4.2. Bovine Serum Albumin
          11.4.3. Recombinant Albumin
     11.5. Market Value (US$ Mn) Forecast By Application
          11.5.1. Blood Volumizer
          11.5.2. Drug Formulation and Vaccines
          11.5.3. Life Sciences
          11.5.4. Others
     11.6. Market Attractiveness Analysis
          11.6.1. By Product Type
          11.6.2. By Application

12. Competition Landscape
     12.1. Market Player – Competition Matrix (By Tier and Size of companies)
     12.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
          12.2.1. CSL Behring LLC
                 12.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.1.2. Product Portfolio
                 12.2.1.3. SWOT Analysis
                 12.2.1.4. Financial Overview
                 12.2.1.5. Strategic Overview
          12.2.2. GRIFOLS INTERNATIONAL, S.A.
                 12.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.2.2. Product Portfolio
                 12.2.2.3. SWOT Analysis
                 12.2.2.4. Financial Overview
                 12.2.2.5. Strategic Overview
          12.2.3. Shire Plc. (Baxalta Inc.)
                 12.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.3.2. Product Portfolio
                 12.2.3.3. SWOT Analysis
                 12.2.3.4. Financial Overview
                 12.2.3.5. Strategic Overview
          12.2.4. Octapharma AG
                 12.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.4.2. Product Portfolio
                 12.2.4.3. SWOT Analysis
                 12.2.4.4. Financial Overview
                 12.2.4.5. Strategic Overview
          12.2.5. InVitria
                 12.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.5.2. Product Portfolio
                 12.2.5.3. SWOT Analysis
                 12.2.5.4. Financial Overview
                 12.2.5.5. Strategic Overview
          12.2.6. Kedrion S.p.A
                 12.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.6.2. Product Portfolio
                 12.2.6.3. SWOT Analysis
                 12.2.6.4. Financial Overview
                 12.2.6.5. Strategic Overview
          12.2.7. HiMedia Laboratories
                 12.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.7.2. Product Portfolio
                 12.2.7.3. SWOT Analysis
                 12.2.7.4. Financial Overview
                 12.2.7.5. Strategic Overview
          12.2.8. Medxbio Pte Ltd
                 12.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.8.2. Product Portfolio
                 12.2.8.3. SWOT Analysis
                 12.2.8.4. Financial Overview
                 12.2.8.5. Strategic Overview
          12.2.9. Mitsubishi Tanabe Pharma Corporation
                 12.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.9.2. Product Portfolio
                 12.2.9.3. SWOT Analysis
                 12.2.9.4. Financial Overview
                 12.2.9.5. Strategic Overview
          12.2.10. Albumedix A/S
                   12.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                   12.2.10.2. Product Portfolio
                   12.2.10.3. SWOT Analysis
                   12.2.10.4. Financial Overview
                   12.2.10.5. Strategic Overview
          12.2.11. Sigma-Aldrich Co. LLC.
                 12.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.11.2. Product Portfolio
                 12.2.11.3. SWOT Analysis
                 12.2.11.4. Financial Overview
                 12.2.11.5. Strategic Overview
          12.2.12. Thermo Fisher Scientific Inc.
                 12.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                 12.2.12.2. Product Portfolio
                 12.2.12.3. SWOT Analysis
                 12.2.12.4. Financial Overview
                 12.2.12.5. Strategic Overview

13. Key Take Away

List of Figures

Figure 01: Global Albumin Market Size, by Product Type (US$ Mn), 2016
Figure 02: Global Albumin Market Share, by Application (% Share), 2016
Figure 03: Albumin market Top trends and drivers
Figure 04: Market Share analysis, by Region
Figure 05: Major drivers of albumin market, by Region
Figure 06: Market Opportunity Map
Figure 07: Key Industry Events
Figure 08: Global Albumin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 09: Market Value Share, by Product Type (2016)
Figure 10: Market Value Share, by Application (2016)
Figure 11: Market Value Share, by Region (2016)
Figure 12: Porter’s Analysis, Albumin Market
Figure 13: Global Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 14: Global Human Serum Albumin Market Revenue (US$ Mn), 2015–2025
Figure 15: Global Bovine Serum Albumin Market Revenue (US$ Mn), 2015–2025
Figure 16: Global Recombinant Albumin Market Revenue (US$ Mn), 2015–2025
Figure 17: Global Albumin Market Attractiveness Analysis, by Product Type
Figure 18: Global Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 19: Global Albumin as Blood Volumizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Albumin for Drug Formulation and Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Albumin for Life Sciences Market Revenue (US$ Mn), 2015–2025
Figure 22: Global Albumin for Other Application Market Revenue (US$ Mn), 2015–2025
Figure 23: Global Albumin Market Attractiveness Analysis, by Application
Figure 24: Global Albumin Market Snapshot, by Country 
Figure 25: Global Albumin Market Value Share Analysis, by Region, 2016 and 2025
Figure 26: Global Albumin Market Attractiveness Analysis, by Region
Figure 27: North America Albumin Market Size (US$ Mn) Forecast, 2017–2025
Figure 28: North America Market Attractiveness Analysis, by Country
Figure 29: North America Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 30: North America Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 31: North America Albumin Market Value Share Analysis, by Country, 2016 and 2025
Figure 32: North America Albumin Market Attractiveness Analysis, by Product
Figure 33: North America Albumin Market Attractiveness Analysis, by Application
Figure 34: Europe Albumin Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017–2025
Figure 35: Europe Albumin Market Attractiveness Analysis, by Country
Figure 36: Europe Albumin Market Value Share Analysis, by Product, 2016 and 2025
Figure 37: Europe Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 38: Europe Albumin Market Value Share Analysis, by Country, 2016 and 2025
Figure 39: Europe Albumin Market Attractiveness Analysis, by Product 
Figure 40: Europe Albumin Market Attractiveness Analysis, by Application
Figure 41: Asia Pacific Albumin Market Size (US$ Mn) Forecast, 2017–2025
Figure 42: Asia Pacific Market Attractiveness Analysis, by Country
Figure 43: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 44: Asia Pacific Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 45: Asia Pacific Albumin Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Asia Pacific Albumin Market Attractiveness Analysis, by Product 
Figure 47: Asia Pacific Albumin Market Attractiveness Analysis, by Application
Figure 48: Rest of the World Albumin Market Size (US$ Mn) Forecast, 2017–2025
Figure 49: Rest of the World Albumin Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 50: Rest of the World Albumin Market Value Share Analysis, by Application, 2016 and 2025
Figure 51: Rest of the World Albumin Market Attractiveness Analysis, by Product 
Figure 52: Rest of the World Albumin Market Attractiveness Analysis, by Application
Figure 53: Breakdown of CSL Behring LLC Net Sales (%Share) , by Region (2016)
Figure 54: CSL Behring LLC Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 55: Breakdown of Grifols International, S.A. Net Sales (%share), by Region (2016)
Figure 56: Grifols International, S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 57: Breakdown of Baxalta, Inc. Net Sales, by Segment, 2015 Revenue (% share) 
Figure 58: Baxalta, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015 (Shire plc)
Figure 59: Octapharma AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 60: Breakdown of Kedrion S.p.A. Net Sales (% Share), by Region (2016)
Figure 61: Kedrion S.p.A.  Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 62: Breakdown of Mitsubishi Tanabe Pharma Corporation Net Sales (% Share), by Region (2015)
Figure 63: Mitsubishi Tanabe Pharma Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 64: Albumedix A/S Breakdown of Net Sales (% Share), by Region (2016)
Figure 65: (Novozyme A/S) Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 66: Breakdown of Net Sales (% Share), by Business Segments (Merck KGaA) (2016)
Figure 67: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016 (Merck KGaA)
Figure 68: Breakdown of Thermo Fisher Scientific, Inc. Net Sales (% Share), by Business segments (2016)
Figure 69: Thermo Fisher Scientific, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016

List of Tables
 
Table 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 03: Global Albumin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 05: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 06: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 07: Europe Albumin Market Value (US$ Mn) Forecast, by Product, 2015–2025
Table 08: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 09: Europe Albumin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2025
Table 11: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 12: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 13: Rest of the World Albumin Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 14: Rest of the World Albumin Market Value (US$ Mn) Forecast, by Application, 2015–2025
 


 
 
Back To Top